Stay updated on Sotatercept in Advanced Lung Cancer Anemia Clinical Trial

Sign up to get notified when there's something new on the Sotatercept in Advanced Lung Cancer Anemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sotatercept in Advanced Lung Cancer Anemia Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:27:53.000Z thumbnail image
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a modification in the dose of sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in participants with advanced non-small cell lung cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:35:50.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for study participants, specifying that researchers are looking for men and women over 18 years of age with histologically confirmed solid tumor malignancies, among other specific health conditions and prior treatments. Previously, no information was provided under the Participation Criteria Collaborators section.
    Difference
    38%
    Check dated 2024-05-22T21:17:52.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:32:02.000Z thumbnail image

Stay in the know with updates to Sotatercept in Advanced Lung Cancer Anemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sotatercept in Advanced Lung Cancer Anemia Clinical Trial page.